» Articles » PMID: 24954823

Impact of the DSM-5 Attention-deficit/hyperactivity Disorder Age-of-onset Criterion in the US Adolescent Population

Overview
Publisher Elsevier
Specialties Pediatrics
Psychiatry
Date 2014 Jun 24
PMID 24954823
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The present study aims to compare the prevalence and clinical correlates of DSM-IV versus DSM-5-defined attention-deficit/hyperactivity disorder (ADHD) and subtypes in a nationally representative sample of US youth based on the age-of-onset criterion.

Method: The sample includes 1,894 participants 12 to 15 years of age from cross-sectional National Health and Nutrition Examination Survey (NHANES) surveys conducted from 2001 to 2004. Data on DSM-IV and DSM-5 criteria for ADHD were derived from administration of the parental ADHD module of the National Institute of Mental Health (NIMH) Diagnostic Interview Schedule for Children, Version IV (DISC-IV).

Results: Extension of the age-of-onset criterion from 7 to 12 years led to an increase in the prevalence rate of ADHD from 7.38% (DSM-IV) to 10.84% (DSM-5). Youth with later age of onset did not differ from those with earlier age of onset in terms of severity and patterns of comorbidity. However, the group with later age of onset was more likely to be from lower income and ethnic minority families.

Conclusion: The comparability of the clinical significance of the early and later age-of-onset groups supports the DSM-5 extension of the age-of-onset criterion in ADHD.

Citing Articles

Psychosocial Interventions for Attention Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis by the CADDRA Guidelines Work GROUP.

Tourjman V, Louis-Nascan G, Ahmed G, DuBow A, Cote H, Daly N Brain Sci. 2022; 12(8).

PMID: 36009086 PMC: 9406006. DOI: 10.3390/brainsci12081023.


Overdiagnosis of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: A Systematic Scoping Review.

Kazda L, Bell K, Thomas R, McGeechan K, Sims R, Barratt A JAMA Netw Open. 2021; 4(4):e215335.

PMID: 33843998 PMC: 8042533. DOI: 10.1001/jamanetworkopen.2021.5335.


Racial Disparities in Diagnosis of Attention-Deficit/Hyperactivity Disorder in a US National Birth Cohort.

Shi Y, Hunter Guevara L, Dykhoff H, Sangaralingham L, Phelan S, Zaccariello M JAMA Netw Open. 2021; 4(3):e210321.

PMID: 33646315 PMC: 7921900. DOI: 10.1001/jamanetworkopen.2021.0321.


Attention-deficit/hyperactivity disorder: diagnostic criteria, epidemiology, risk factors and evaluation in youth.

Cabral M, Liu S, Soares N Transl Pediatr. 2020; 9(Suppl 1):S104-S113.

PMID: 32206588 PMC: 7082246. DOI: 10.21037/tp.2019.09.08.


Effectiveness of a Tailored Intervention for Women With Attention Deficit Hyperactivity Disorder (ADHD) and ADHD Symptoms: A Randomized Controlled Study.

Gutman S, Balasubramanian S, Herzog M, Kim E, Swirnow H, Retig Y Am J Occup Ther. 2020; 74(1):7401205010p1-7401205010p11.

PMID: 32078512 PMC: 7018471. DOI: 10.5014/ajot.2020.033316.


References
1.
Bailey R, Ali S, Jabeen S, Akpudo H, Avenido J, Bailey T . Attention-deficit/hyperactivity disorder in African American youth. Curr Psychiatry Rep. 2010; 12(5):396-402. DOI: 10.1007/s11920-010-0144-4. View

2.
Yoshimasu K, Barbaresi W, Colligan R, Voigt R, Killian J, Weaver A . Childhood ADHD is strongly associated with a broad range of psychiatric disorders during adolescence: a population-based birth cohort study. J Child Psychol Psychiatry. 2012; 53(10):1036-43. PMC: 3608464. DOI: 10.1111/j.1469-7610.2012.02567.x. View

3.
Froehlich T, Lanphear B, Epstein J, Barbaresi W, Katusic S, Kahn R . Prevalence, recognition, and treatment of attention-deficit/hyperactivity disorder in a national sample of US children. Arch Pediatr Adolesc Med. 2007; 161(9):857-64. DOI: 10.1001/archpedi.161.9.857. View

4.
Bianchini R, Postorino V, Grasso R, Santoro B, Migliore S, Burlo C . Prevalence of ADHD in a sample of Italian students: a population-based study. Res Dev Disabil. 2013; 34(9):2543-50. DOI: 10.1016/j.ridd.2013.05.027. View

5.
Pliszka S . Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2007; 46(7):894-921. DOI: 10.1097/chi.0b013e318054e724. View